FOXO TECHNOLOGIES INC. Business Combination Price Of Acquisition Expected
FOXO TECHNOLOGIES INC. (FOXO) reported Business Combination Price Of Acquisition Expected of $1.16 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Description
us-gaap:BusinessCombinationPriceOfAcquisitionExpected · last filed 2024-06-06
- FOXO TECHNOLOGIES INC. business combination price of acquisition expected for fiscal 2022 was $1.16M.
| Period end | Business Combination Price Of Acquisition Expected | Business Combination Price Of Acquisition Expected 12 month |
|---|---|---|
| 2022-12-31 | $1.16M 10-K · filed 2023-03-31 | |
| 2021-08-20 | $1.16M 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |